Total Funding
54
Total FundingPrivate Equity raised
Growth Score in past quarter
pts
Heat Score 54 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
OncoQuest is a Edmonton-based biopharmaceutical company.
- Hany Awadalla: Senior Vice president & CFOPast Role: Wells Fargo, Managing Director
Quest PharmaTech
About the Company
The Company has assembled several bioactive technologies, including human and xenotypic monoclonal antibodies of the IgG and IgE class that can induce tumor specific immunity and enhance clinical outcome. Several of the lead components have clinical track records and extensive development dossiers that can be exploited to be integral to
combinatorial immunooncology treatment strategies.
